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The glomerular capillary wall functions as an efficient barrier
that restricts the passage of plasma proteins and allows a high
flow rate of filtration for plasma water and small solutes.
Experimental studies have confirmed the theoretical predic-
tions that circulating macromolecules are retained within the
lumen of glomerular capillaries because of their size, shape and
electrical charge [1—6]. The selective function of the glomerular
capillary wall allows an almost complete restriction of large
proteins and albumin while low molecular weight proteins are
almost freely filtered and reabsorbed at tubular level [7, 8].
Glomerular permeability to circulating macromolecules has
been extensively studied in the last few years, both by experi-
mental studies and clinical investigations, with the aim of
elucidating the mechanisms by which the glomerular membrane
loses its selective function during development of most glomer-
ular diseases. More recently additional interest in this area has
been generated by the observation that the use of angiotensin
converting enzyme (ACE) inhibitors in experimental models of
glomerular dysfunction and in patients, beside reducing blood
pressure, prevents or lessens urinary protein excretion. Exper-
imental research in this field has focused on the mechanisms by
which such pharmacological treatment can restore, at least
partially, the selective function of the glomerular barrier [9—121.
The objective of this communication is to review some recent
developments in experimental and clinical research on glomer-
ular selectivity that illustrate new aspects of the glomerular
charge- and size-selective function. In particular, recent studies
are reviewed that indicate the distribution of restrictive sites on
the glomerular basement membrane (GBM) to the filtration of
albumin. Since recent evidence indicates that epithelial cells, in
addition to GBM, exert a major role in determining the selective
function of the glomerular capillary wall, other studies are
discussed which aimed to clarify whether there was a correla-
tion between changes in permselective function and quantifica-
tion of structural changes of glomenilar cells as assessed using
morphometrical techniques. Observations on the filtration of
test macromolecules with different configuration are also pre-
sented since they provide new insights on the effects of molec-
ular configuration on the filtration of test macromolecules.
Theoretical analysis of experimental results obtained with these
test macromolecules has been carried out to determine mem-
brane permeability parameters in both the normal state and in a
model of glomerular injury in the rat. Both theoretical analyses
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are reviewed because they indicate that glomerular size-selec-
tive function is more restrictive than that estimated previously
by experimental and human studies.
The functional nature of the glomerular filtration barrier
The glomerular membrane effectively restricts the passage of
plasma proteins as a function of their size and of their electrical
charge [13—16]. However, the precise location within the gb-
merular capillary wall of that barrier and the factors that
determine size and charge selectivity are still not well-defined.
Several studies have been undertaken to investigate the loca-
tion of the filtration barrier for circulating proteins. Original
observations [17, 18] noted that albumin and IgG were retained
at the endothelial level of the lamina densa of the GBM.
Bendayan and coworkers [19, 20], by immunohistochemical
staining, provided experimental evidence that albumin distribu-
tion within the GBM in the physiological state is determined by
two distinct restrictive sites, one at the endothelial basal
membrane, the other on the endothelial side of the lamina
densa. According to other studies, these restrictive sites are lost
in diabetic rats and in the nephrotic syndrome in humans.
Furthermore, these investigators reported that localization of
electrically modified albumin within the GBM is a function of its
charge [21]. An electrostatic anionic barrier seems to be local-
ized at the level of the lamina rara interna and externa, while the
lamina densa acts more as a size-selective filter. These confirm
previous observations on the deposition of electron-dense trac-
ers within the GBM [151. Similar results have been obtained by
other investigators using immunocytochemical localization of
albumin, IgG and transferrin in normal rats combined with in
situ drip fixation of kidney tissue [221. According to these
authors the central and outer zones of the GBM act as charge
restrictive barrier, while a more generalized size restriction of
the whole GBM is suggested by the continuous localization of
uncharged proteins throughout its depth. Taken together these
investigations would suggest that under normal circumstances
the selective permeability of the GBM is based on an efficient
barrier acting on both the charge and size of circulating macro-
molecules.
Other components of the glomerular capillary wall are also
likely to play a crucial role in determining the permselective
function of glomerular membrane [23—271. Daniels and cowork-
ers have documented that protein permeability of GBM in vitro
is much higher than that of intact glomeruli, suggesting a major
contribution of endothelial and epithelial cells in glomerular
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filtration of proteins [24]. In addition the same authors, mea-
suring the passage of tracer macromolecules across intact or
cell free glomerular membranes in vitro, have indicated that
epithelial cells are the major determinants of the size- and
charge-selective properties of the glomerular capillary wall [23].
It is also generally acknowledged that effacement and fusion of
epithelial cells podocytes is associated with an altered size
selective function of glomerular membrane [25, 28]. However,
the mechanisms by which epithelial cell podocytes exert a
filtration barrier function for macromolecules have not been
completely elucidated.
Ultrastructural changes associated with glomerular
permselective dysfunction
Experimental studies in laboratory animals and in humans,
using neutral dextrans as tracer macromolecules, indicate that
the glomerular capillary wall acts as a membrane perforated by
pores having a continuous distribution of radii. The mean radius
of the pore-size population has been estimated to be around
50 A in both rats and humans [29, 30]. This hypothetical
description of the glomerular capillary wall is not based on data
derived from ultrastructural analysis of the glomerular mem-
brane but rather represents a quantitative description of intrin-
sic membrane permeability properties to macromolecules. At
the moment it is not yet clear which components of the
glomerular barrier effectively exert the selective barrier to the
passage of circulating macromolecules. The GBM, by its phys-
icochemical composition, plays an important role in determin-
ing both glomerular charge- and size-selectivity. Detailed char-
acterization of different GBM proteins and their role in this
selective function is a complex task that is currently under
investigation. In order to determine whether changes in GBM
structure are associated with functional alterations, studies
have also been undertaken with the aim of measuring simulta-
neously GBM thickness and protein filtration.
The epitheial podocytes, with their slit diaphragms, could
also play an important role in the glomerular permselective
function. This suggestion is based on the observation that
fusion or effacement of foot processes of the epithelial cells is
associated with abnormal protein filtration and loss of size-
selective function [25, 28].
Quantification of structural changes of glomerular membrane
components has been performed using morphometric analysis.
GBM thickness, the number of epithelial slit pores per unit
length of GBM and epithelial filtration slit width have been
assessed and compared with measurements of albumin and IgG
fractional clearance. Kiberd provided convincing results that,
in a model of murine lupus nephritis, structural changes of the
glomerular capillary wall are related to abnormal filtration of
albumin and IgG [31]. In this model, albumin and IgG fractional
clearances correlated significantly with the number of epithelial
slits per unit length of GBM, and with GBM thickness. Inter-
estingly, however, no significant correlation between the width
of filtration slits, and fractional clearances of albumin and IgG
was observed. Fogel and coworkers [32] also reported that in
passive Heymann nephritis, the rat model of membranous
nephropathy, GBM width is increased, compared to normal
controls, and the number of slit pores per m of GBM is
significantly decreased. In contrast it has been reported that
GBM thickness in subtotal nephrectomized rats is decreased,
rather than increased, as compared to controls [33]. We have
recently performed similar measurements with the aim of
investigating whether differences in proteinuna correlate with
changes in glomerular capillary wall structure in male MWF/
Ztm rats treated with an ACE inhibitor [34]. In treated animals
the spontaneous development of proteinuria, was completely
prevented. Despite the important difference in urinary protein
excretion rates, however, untreated and treated animals
showed comparable GBM thickness as well as comparable
epithelial slit frequency. Similar observations were reported by
Guasch and coworkers in human pathological conditions, min-
imal change nephropathy and focal glomerulosclerosis [35]. In
this study abnormal increases in albumin and IgG fractional
clearance were associated with a decreased frequency of epi-
thelial filtration slits. However, despite abnormal fractional
clearances of albumin and IgG, no statistically significant dif-
ferences was observed in GBM thickness between controls and
nephrotic groups. These results would indicate that changes in
epithelial podocyte structure, but not in GBM thickness, are
related to abnormal filtration of circulating proteins.
Altogether these results indicate that structural alterations of
the glomerular capillary are not invariably related to abnormal
filtration of circulating proteins. In different pathological con-
ditions, in rats and in patients, different mechanisms seem to
lead to different structural and functional changes of the gb-
merular capillary wall. Thus, more comprehensive studies must
be performed in the near future to document in more detail the
structural alterations of the glomerular capillary wall and their
actual relationship to the loss of selective function and abnor-
mal protein filtration.
Effect of molecular configuration on glomerular filtration of
macromolecules
The size-selective function of the glomerular membrane has
been extensively investigated measuring glomerular filtration of
neutral test macromolecules [9—12, 29, 30, 35—37]. If a test
macromolecule is filtered at glomerular level, but neither se-
creted nor reab sorbed by the tubule, its urinary clearance is a
direct measure of its glomerular filtration. In this condition, the
urinary clearance of such a macromolecule, factored by the
clearance of a freely filtered molecule (like inulin), represents
the filtrate-to-plasma concentration ratio, usually termed frac-
tional clearance or "sieving coefficient" of the glomerular
capillary wall. It has been demonstrated that neutral dextrans
are filtered at glomerular level with negligible reabsorption at
tubular level [2]. Because of this property and because of their
relative safety in patients, these molecules have been used to
determine the sieving properties of the glomerular capillary
wall. We and others have determined the sieving coefficient of
the glomerular membrane in experimental and human studies
measuring the clearance of neutral dextran molecules of varing
sizes. These studies illustrate that fractional clearances of
neutral macromolecules are useful in determining size-selective
defects in experimental animals and in human glomerular dis-
eases, and they can be used to investigate the effect of treat-
ment of glomerular dysfunction with pharmacological interven-
tions aimed at ameliorating glomerular size-selective function
[10—12]. Despite numerous studies focusing on the relation
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between glomerular filtration of neutral dextrans and that of
proteins, the test macromolecules have a molecular configura-
tion that is far from being globular, but are rather elongated in
shape (most plasma proteins are globular. This limitation in-
duced some investigators to assess whether other neutral mac-
romolecules (like Ficoll), more globular in shape, have a
different rate of filtration across the glomerular membrane.
Deen and coworkers measured fractional clearance of Ficoll of
graded sizes in normal Munich- Wistar rats [38] and showed that
sieving coefficients for all radii studied were significantly lower
than that measured in the same study for neutral dextran
macromolecules. In the normal Munich-Wistar rat, the mean
fractional clearance for a dextran macromolecule of 35 A in
radius (approximately the molecular radius of albumin) aver-
aged 0.09 while the fractional clearance of Ficoll molecules of
the same size averaged only 0.008. More recently, we measured
fractional clearance of Ficoll of graded sizes in normal and in
diabetic Sprague-Dawley rats after long-term observation [39].
As in the normal Munich-Wistar rats, fractional clearances of
these molecules in normal Sprague-Dawley rats were signifi-
cantly lower than corresponding fractional clearance values of
neutral dextrans previously measured [30]. Thus, in this strain
of rats fractional clearance of dextran molecules of 35 A in
radius averaged 0.17 [30] and that of Ficoll of same size
averaged only 0.020 [39].
Since fractional clearance of albumin in the normal rat is
estimated to be around 0.003 [7], it is understandable that
earlier studies, using neutral dextran, suggested a more prom-
inent role of charge- than of size-selectivity for albumin exerted
by the glomerular membrane. The new data obtained with
Ficoll, however, show that a large portion of albumin restriction
must derive from the size-selective function of the capillary
wall. This would imply that both charge- and size-selectivity
defects must be responsible for abnormal albumin filtration in
experimental and human glomerular diseases.
Theoretical analysis of glomerular size-selective function
The glomerular size-selective function has been mainly de-
rived from the measurement of fractional clearance of neutral
test macromolecules. Theoretical and experimental observa-
tions [2, 4, 6] indicated that the membrane passage of macro-
molecules is affected by changes in the hemodynamic condi-
tions of the glomerular capillaries. Changes in the determinants
of glomerular ultrafiltration may increase or decrease the filtra-
tion of a test macromolecule. Thus, an increase in protein
concentration in the afferent arteriole or in the ultrafiltration
coefficient increases macromolecule filtration while a decrease
in afferent plasma flow or transmembrane hydraulic pressure
difference decreases macromolecule filtration. This implies
that, when glomerular filtration of test macromolecules is used
to investigate glomerular size-selective function, with concom-
itant changes in glomerular hemodynamics, it is impossible to
separate the extent to which the ifitration of solute markers is
influenced by effective changes in glomerular membrane per-
meability properties and which changes are the result of alter-
ations in local hemodynamic conditions. In the last fifteen years
mathematical models of glomerular size-selective function have
been developed and used to separate these two effects and
allow estimation of effective changes in glomerular membrane
permeability to macromolecules. These models are based on
the application of the pore theory to solute transport across the
glomerular membrane and consider the changes in local con-
centration of test macromolecules [4, 29]. Thus, they allow an
analysis of intrinsic membrane permeability parameters in
terms of the radii of hypothetical pores assumed to perforate the
glomerular capillary wall.
These models were originally developed assuming the gb-
merular membrane to be perforated by pores of uniform radius
[4]. This assumption did not completely reflect the behavior of
solute transport at glomerular level. Many experimental and
human diseases are characterized by the abnormal passage of
large neutral test macromolecules (larger than 60 A in radius)
and by a concomitant reduction in the filtration of small
molecules [29, 40]. For these reasons theoretical models have
been extended to allow consideration of the glomerular mem-
brane as a barrier perforated by a continuous population of
pores of different sizes [29, 30]. These models, known has
heteroporous models, have been successfully applied to the
analysis of fractional clearance data in experimental and in
clinical studies. Among them, two models of the glomerular
membrane pore size distributions have been used most fre-
quently, the so called "isoporous plus shunt" model and the
"lognormal" distribution model. The first considers the mem-
brane as perforated by two pore populations, one represented
by restrictive pores with uniform radius and another repre-
sented by pores, few in number but large in size, that offer no
resistance to the passage of the test macromolecules, and
represent a shunt pathway for macromolecules. The two pop-
ulations are described, respectively, by the radius (r0) and the
rate of movement of ifitrate through the shunt if plasma protein
were absent (coo).
The lognormal distribution model is based on the assumption
that the pore size distribution is the logarithmic transformation
of the normal probability distribution function. The parameters
that describe this distribution (u and s) are, respectively, the
values of the mean and the standard deviation of the corre-
sponding normal distribution. A summary of membrane pore-
size parameters calculated using fractional clearance values of
dextran molecules and the two different pore-size distributions
is shown in Table 1. As seen in the table, theoretical analysis
based on the isoporous plus shunt model suggested that in the
experimental animal and in the human condition the radius of
selective pores is respectively around 45A and 55 A, while the
shunt pathway differs by about one order of magnitude (1 x
iO and ito 10 x 10) between the two conditions. Using the
isoporous plus shunt model pore-size distribution, patients
affected by various form of glomerular diseases showed only
slight changes in pore-size parameters. A similar pattern is
shown by consideration of pore-size distribution according to
the lognormal probability function. Membrane parameters ob-
tained using this model indicate that the major component of
pore-size distribution has a peak at 42 A and 55 A, respectively
for experimental animals and humans under normal conditions,
and that the spread of the pore-size population is higher in the
rat than in humans (Table 1). Comparing data obtained in
normal and in pathological conditions in humans, it appears that
the mean pore size decreases in the disease state and the spread
of the distribution increases. These theoretical models have
been recently used also to investigate effective changes in
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Table 1. Membrane pore-size parameters in experimental animals and humans derived from fractional clearance of neutral dextran and Ficoll
Species Condition Tracer Model Pore-size parameters Reference
Rat
Human
Human
Rat
Human
Human
Rat
Rat
Rat
Normal
Normal
Glom. disease
Normal
Normal
Glom. disease
Normal
Normal
Glom. disease
Dextran
Dextran
Dextran
Dextran
Dextran
Dextran
Ficoll
Ficoll
Ficoll
Isoporous +
Isoporous +
Isoporous +
Log normal
Log normal
Log normal
Isoporous +
Log normal
Log normal
shunt
shunt
shunt
shunt
r0 = 48—44 A
r0 = 57 A
r0 = 52—56 A
u = 42—43 A
u = 55 A
u = 42—49 A
r0 = 29 A
u = 6—14 A
u = 24 A
= 0.1 —
= 1.3 —
= 2.5 —
s = 1.17 —
s = 1.10
s = 1.17 —
= 0.5 x
s = 1.46 —
s = 1.35
5.0 x
1.8 X
11.3 x
1.19
1.24
l0—
1,64
iOiOiO
[1, 2]
[3, 4]
[3—7]
[8, 9]
[3]
[10, 11]
[2]
[2, 12]
[121
Abbreviations are: r0 and W. pore-size parameters for the isoporous plus shunt model; u and s, pore-size parameters for the log normal
distribution.
membrane sieving properties induced by pharmacological treat-
ments in experimental and human studies [10, 11, 41]. In
general these theoretical analyses show that loss of glomerular
membrane selective function is associated with the appearance
of large pores that allow an increased filtration of circulating
proteins.
The theoretical analysis so far described, however, is based
on the assumption that solute molecules are spherical in shape.
The test macromolecules adopted in the above-mentioned stud-
ies (neutral dextrans) are not spherical in shape but rather
characterized by an elongated shape with a random-coil config-
uration [38]. We have already discussed the ability of Ficoll
molecules to behave more like an ideal probe for determining
glomerular pore size than the conventionally used dextrans. For
these reasons fractional clearance of Ficoll was recently used to
compute membrane pore-size parameters and to compare them
with values calculated for dextran molecules [38, 39]. As
reported in Table 1, new measurements of size-selective func-
tion in normal rats performed using Ficoll indicate that mean
pore size is much smaller than that derived from dextran
clearances. Using the isoporous plus shunt model, it was
calculated that the restrictive pores have a radius of only 29 A
for normal rat and a mean pore size, calculated with the
lognormal distribution model, less than 15 A in radius. This is
confirmed by our observation that the mean pore radius of the
lognormal distribution for the Sprague-Dawley rat averaged
42 A using dextran fractional clearances and only 18 A for Ficoll
fractional clearance [30, 391. Thus, a completely different
picture is shown by these theoretical analyses. Since albumin,
the major urinary protein of glomerular origin, has a size of 35 A
it appears that it can not be filtered through the majority of the
membrane pores on the basis of its relative size. This indicates
that a charge-selective defect of the glomerular capillary wall
may cause important changes in albumin filtration only if
associated with a size-selectivity defect. These observations
change previous considerations on the relative importance of
charge- and size-selectivity and better define the absolute
quantification of glomerular size-selective function in the exper-
imental animal. On the basis of these results it appears that the
use of Ficoll fractional clearance in humans would give addi-
tional useful information on the glomerular barrier. However,
to what extent it would affect computation of pore-size param-
eters in the normal condition and in glomerular diseases is not
known at the moment. To obtain such results the limitations
connected with the use of these tracer molecules in man must
first be overcome.
Conclusions
In the last few years efforts have been devoted to the detailed
study of the structural and functional nature of glomerular
selective function in the hope to identify the mechanisms
responsible for altered permeability of the glomerular capillary
wall to circulating macromolecules. Since this condition char-
acterizes several glomerular diseases that progress to end-stage
renal failure, it is believed that a better understanding of the
causes responsible for proteinuria will lead to development of
new therapeutical interventions aimed at reducing glomerular
injury and retarding the onset of renal failure [42]. The func-
tional nature of changes in the selective properties of the
glomerular capillary wall that follows glomerular injury have
been explored by studies of endogenous albumin distribution
which revealed that the barrier normally localized in the sub-
endothelial area of the GBM is lost in proteinuric glomerular
disease, while other studies indicate a crucial role for epithelial
cell slit diaphragms. No details exist which define the structural
nature of the barrier which opposes the passage of macromol-
ecules from the capillary lumen into the urinary space under
normal conditions. The transmembrane passage of non-reab-
sorbable dextrans has been used to probe the passage of
circulating macromolecules and proteins. Interpreting dextran
data on the basis of the pore theory allowed an understanding of
the intrinsic membrane properties that prevented the passage of
macromolecules in normal circumstances and their selective
alterations in glomerular disease. However, more recent studies
showed that the use of dextrans as filtration probes does not
fully explain the relatively high sieving coefficient of normal
animals in the absence of proteinuria. Charge-selectivity has
been advocated as a possible explanation, since albumin is
negatively charged. This does not apply, however, to the G
class of immunoglobulins that are mainly neutral proteins. In
this context data generated by the use of a different filtration
probe (that is, Ficoll), that difuses less than dextrans due to its
spherical configuration, offers a better way to analyze the
consequences of glomerular injury on barrier permeability to
macromolecules. Models based on the application of the pore
theory to solute transport across the glomerular membrane are
becoming more sophisticated in recent years. Combining the
use of new probes with more reliable models will allow, in the
near future, a more close definition of the functional nature of
altered permselectivity in glomerular diseases.
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